Intervention Protocol

Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention

  1. Chen Mao1,
  2. Zu-Yao Yang1,
  3. Vincent CH Chung2,
  4. Ying Qin1,
  5. Wilson Tam1,
  6. Joey SW Kwong3,
  7. Wei Xie4,
  8. Jin Ling Tang5,*,
  9. Yafang Huang1,
  10. Jin-Qiu Yuan1

Editorial Group: Cochrane Heart Group

Published Online: 12 DEC 2012

DOI: 10.1002/14651858.CD010237

How to Cite

Mao C, Yang ZY, Chung VCH, Qin Y, Tam W, Kwong JSW, Xie W, Tang JL, Huang Y, Yuan JQ. Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD010237. DOI: 10.1002/14651858.CD010237.

Author Information

  1. 1

    The Chinese University of Hong Kong, Division of Epidemiology, School of Public Health and Primary Care, Hong Kong, China

  2. 2

    Chinese University of Hong Kong, Jockey Club School of Public Health and Primary Care, NT, Hong Kong, Hong Kong

  3. 3

    The Chinese University of Hong Kong, Division of Cardiology & Heart Education And Research Training (HEART) Centre, Department of Medicine and Therapeutics, Prince of Wales Hospital, & Institute of Vascular Medicine, Shatin, New Territories, Hong Kong

  4. 4

    School of Chinese Medicine, Southern Medical University, Chinese Medicine, Guangzhou, Guangdong, China

  5. 5

    The Chinese University of Hong Kong, School of Public Health and Primary Care, New Territories, Hong Kong, China

*Jin Ling Tang, School of Public Health and Primary Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Satin, New Territories, Hong Kong, China. jltang@cuhk.edu.hk.

Publication History

  1. Publication Status: New
  2. Published Online: 12 DEC 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To systematically assess the efficacy and safety of Tong-xin-luo capsules in preventing cardiovascular events for patients with coronary heart disease after PCI.